About Keen Eye
Keen Eye is a Healthcare company based in France founded in 2013. Manufacturer of drug development services for image analysis. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Keen Eye was founded in 2013 and is based in France. Image analysis services are manufactured for the pharmaceutical sector, supporting drug development processes. Operations involve the creation of tools and solutions for analyzing medical images to aid research and testing. The company focuses on biotechnology applications, with activities centered in Europe to serve international clients in the health sciences field.
- Headquarters France
- SectorsHealthcare
- Website keeneye.ai
- Social LinkedIn X
- Latest Funding Round$610.03K (USD), Grant
Jan 2020
- Investors
Funding Insights of Keen Eye
- Total Rounds 1
- Last Round Grant — $610,032
- First Round $610,032
(Jan 2020)
- Investors Count 1
All 1 funding rounds of Keen Eye with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2020 | $610,032 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Keen Eye
Keen Eye has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Keen Eye
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Keen Eye
2 dated milestones of Keen Eye across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Keen Eye is founded.
- Funding First funding round of $610K.
Top companies in Clinical IT & Data Platforms
2 companies that operate in the same segment as Keen Eye (Clinical IT & Data Platforms) in France, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | 1,606 | ||
Work tech company offering meal and gift vouchers for employees | 2016 | Paris, Ile de France, France | USD 328.44 M | USD 69.96 M | 757 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Keen Eye
Complete news archive for Keen Eye
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keen Eye
Keen Eye was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Keen Eye is headquartered in France.
Keen Eye was founded in 2013 and is based in France. Image analysis services are manufactured for the pharmaceutical sector, supporting drug development processes. Operations involve the creation of tools and solutions for analyzing medical images to aid research and testing. The company focuses on biotechnology applications, with activities centered in Europe to serve international clients in the health sciences field.
Keen Eye has 1 investor. Key investors include European Union.